Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
No Recourse for Doctor Claiming Defamation
Brooklyn Supreme Court Justice Marsha Steinhardt ruled on July 17 that statements made by a physical therapist in preparation for a medical malpractice case being brought by a patient against a doctor (Yoshida v. Chin' 24149/2008) are absolutely privileged and cannot form the basis for the doctor's defamation claim against the physical therapist. The latter, Kwan Park, had signed a statement saying that the doctor used a power drill on the patient's injured shoulder, and that Kwan had held the patient down during this procedure. The doctor denied that these events ever happened, and claimed defamation. Justice Steinhardt, although conceding that the statement could harm the doctor's reputation and practice, nevertheless declared it off-limits as a basis for a defamation claim.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.